Yuki Muranishi

Yuki Muranishi

Auto-generated profile, based on publicly available information

Yuki Muranishi

Department of Renal and Genitourinary Surgery Hokkaido University Graduate School of Medicine Sapporo Japan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2024 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
YMYuki Muranishi
Yuki Muranishi
YKYoshitomo Kobori
Yoshitomo Kobori
YKYuko Katoh-Fukui
Yuko Katoh-Fukui
STSatoshi Tamaoka
Satoshi Tamaoka
AHAtsushi Hattori
Atsushi Hattori
MFMaki Fukami
Maki Fukami
Do copy-number variations (CNVs) in the azoospermia factor (AZF) regions and monogenic mutations play a major role in the development of isolated (non-syndromic) non-obstructive azoospermia (NOA) in Japanese men with a normal 46, XY karyotype? Deleterious CNVs in the AZF regions and damaging sequence variants in eight genes likely constitute at least 8% and approximately 8% of the genetic causes, respectively, while variants in other genes play only a minor role. Sex chromosomal abnormalities, AZF-linked microdeletions, and monogenic mutations have been implicated in isolated NOA. More than 160 genes have been reported as causative/susceptibility/candidate genes for NOA. Systematic molecular analyses were conducted for 115 patients with isolated NOA and a normal 46, XY karyotype, who visited our hospital between 2017 and 2021. We studied 115 unrelated Japanese patients. AZF-linked CNVs were examined using sequence-tagged PCR and multiplex ligation-dependent probe amplification, and nucleotide variants were screened using whole exome sequencing (WES). An optimized sequence kernel association test (SKAT-O), a gene-based association study using WES data, was performed to identify novel disease-associated genes in the genome. The results were compared to those of previous studies and our in-house control data. Thirteen types of AZF-linked CNVs, including the hitherto unreported gr/gr triplication and partial AZFb deletion, were identified in 63 (54.8%) cases. When the gr/gr deletion, a common polymorphism in Japan, was excluded from data analyses, the total frequency of CNVs was 23/75 (30.7%). This frequency is higher than that of the reference data in Japan and China (11.1% and 14.7%, respectively). Known NOA-causative AZF-linked CNVs were found in nine (7.8%) cases. Rare damaging variants in known causative genes (DMRT1, PLK4, SYCP2, TEX11, and USP26) and hemizygous/multiple-heterozygous damaging variants in known spermatogenesis-associated genes (TAF7L, DNAH2, and DNAH17) were identified in nine cases (7.8% in total). Some patients carried rare damaging variants in multiple genes. SKAT-O detected no genes whose rare damaging variants were significantly accumulated in the patient group. The number of participants was relatively small, and the clinical information of each patient was fragmentary. Moreover, the pathogenicity of identified variants was assessed only by in silico analyses. This study showed that various AZF-linked CNVs are present in more than half of Japanese NOA patients. These results broadened the structural variations of AZF-linked CNVs, which should be considered for the molecular diagnosis of spermatogenic failure. Furthermore, the results of this study highlight the etiological heterogeneity and possible oligogenicity of isolated NOA. This study was supported by Grants from the Japan Society for the Promotion of Science (21K19283 and 21H0246), the Japan Agency for Medical Research and Development (22ek0109464h0003), the National Center for Child Health and Development, the Canon Foundation, the Japan Endocrine Society, and the Takeda Science Foundation. The results of this study were based on samples and patient data obtained from the International Center for Reproductive Medicine, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan. The authors have no conflicts of interest to disclose. N/A.

1 January 2024 in Reproductive Medicine and Biology
Verified
Journal Article
Open access
YMYuki Muranishi
Yuki Muranishi
YKYuko Katoh‐Fukui
Yuko Katoh‐Fukui
AHAtsushi Hattori
Atsushi Hattori
YKYoshitomo Kobori
Yoshitomo Kobori
AOAkiyoshi Osaka
Akiyoshi Osaka
MFMaki Fukami
Maki Fukami
Case: A 40‐year‐old Japanese man with nonobstructive azoospermia (NOA) was found to carry rare variants in KCTD19, a newly identified causative gene for spermatogenic failure. This patient was identified through mutation screening of KCTD19 in 97 men with etiology‐unknown isolated NOA.Outcome: The patient had two heterozygous variants in KCTD19 that affect consensus sequences of splice‐donor sites [c.300+2T>A and c.2667C>T (p.E889E)]. Both variants were predicted to cause exon skipping. Long‐read sequencing confirmed the compound heterozygosity of the variants. The patient exhibited small testes and a mildly elevated level of follicle‐stimulating hormone but no other phenotypic abnormalities. Testicular histology showed borderline findings between spermatocyte maturation arrest and severe hypospermatogenesis.Conclusion: These results provide evidence that biallelic loss‐of‐function variants of KCTD19 represent rare causes of isolated NOA.

4 May 2026 in International Journal of Urology
Verified
Journal Article
Closed access
YMYuki Muranishi
Yuki Muranishi
TOTakahiro Osawa
Takahiro Osawa
YHYurie Hirata
Yurie Hirata
MHMadoka Higuchi
Madoka Higuchi
HCHiroki Chiba
Hiroki Chiba
TATakashige Abe
Takashige Abe